High Court Won't Hear Off-Label Ad Suit Against Taro
The U.S. Supreme Court on Monday shot down a bid to revive a suit that claimed that Taro Pharmaceutical USA Inc. promoted off-label uses of a heart medication, refusing to take...To view the full article, register now.
Already a subscriber? Click here to view full article